News | Cath Lab | December 28, 2015

Boston Scientific Chariot Guiding Sheath May Break off During Procedures

December 28, 2015 — The U.S. Food and Drug Administration (FDA) said Boston Scientific has started a Class I recall of its Chariot Guiding Sheath after receiving 14 complaints of the shaft of the device separating. This can cause small pieces to break off the device and enter the patient’s bloodstream. 

The FDA said these emboli might obstruct blood flow and require additional interventions to remove device fragments. Obstructed blood flow can result in serious patient injuries such as stroke, kidney damage, damage to the intestines or limbs, or can cause patient death.

On Dec. 15, Boston Scientific sent an urgent medical device recall removal letter to their customers. In the letter they instructed customers to immediately stop using and quarantine any affected products. These products should be returned to the vendor.

Additionally, physicians are encouraged to contact all patients who have undergone procedures involving Chariot to confirm their post-procedure status, as device shaft separation and embolized fragments may not have been recognized at the time of the procedure.

The U.S. recall includes 5,692 units nationwide. The affected device manufacturing dates and between March 17, 2015 to Nov. 10, 2015 and had distribution dates from June 6, 2015 to Nov. 17, 2015

The Chariot Guiding Sheath is used to guide the placement of interventional and diagnostic devices into the veins and arteries of a patient’s arms, hands, legs or feet (peripheral vasculature).

The recall affects all UPNs of the Chariot Guiding Sheaths:

  • H74939277645110
  • H74939277745110
  • H74939277845110
  • H74939277645220
  • H74939277765120
  • H74939277690210
  • H74939277665110
  • H74939277790110
  • H74939277645120
  • H74939277865120
  • H74939277690220
  • H74939277690110
  • H74939277865110
  • H74939277745120
  • H74939277890120
  • H74939277845210
  • H74939277765110
  • H74939277545210
  • H74939277790210
  • H74939277845120
  • H74939277745210
  • H74939277545110
  • H74939277790220
  • H74939277790120
  • H74939277745220
  • H74939277645210
  • H74939277690120
  • H74939277665120
  • H74939277890110

Physicians and health care facilities with questions can contact their Boston Scientific representative or call (800) 811-3211.

 

Related Content

Sponsored Content | Videos | Cath Lab | October 24, 2018
Michael Flaherty, M.D., discusses a study published in Circulation Research which finds that use of hemodynamic suppo
Philips Showcases Integrated Solutions for Cardiovascular Care at TCT 2018
News | Cath Lab | September 20, 2018
At the Transcatheter Cardiovascular Therapeutics (TCT) annual meeting, Sept. 21–25 in San Diego, Philips is showcasing...
Sponsored Content | Videos | Cath Lab | September 19, 2018
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) datab
A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. DAIC staff photo by Dave Fornell

A complex PCI case to revascularize a chronic total occlusion (CTO) at Henry Ford Hospital in Detroit. Complex PCI and CHIP cases are increasing patient volumes in the cath lab and using a minimally invasive approach in patients who otherwise would have been sent for CABG. Pictured is Khaldoon Alaswad, M.D. (right) who is proctoring a fellow in treating CTOs.

Feature | Cath Lab | September 13, 2018 | Artur Kim, Kamran Zamanian
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and tre
Videos | Cath Lab | August 13, 2018
Jeffrey Schussler, M.D., FACC, FSCAI, FSCCT, FACP, interventional cardiologist at Baylor Scott White Heart and Vascul
Shockwave Launches Coronary Intravascular Lithotripsy in Europe
News | Cath Lab | May 30, 2018
Shockwave Medical recently announced the European commercial availability of Intravascular Lithotripsy (IVL) for...
FFR software on the GE Centricity CVIS. A trial from the 2018 EuroPCR meeting showed FFR improves long-term outcomes.
News | Cath Lab | May 29, 2018
May 29, 2018 — Ongoing controversy exists regarding the role of percutaneous coronary intervention (PCI) for stable c
Overlay Init